SE9604752D0 - Formulation and use - Google Patents

Formulation and use

Info

Publication number
SE9604752D0
SE9604752D0 SE9604752A SE9604752A SE9604752D0 SE 9604752 D0 SE9604752 D0 SE 9604752D0 SE 9604752 A SE9604752 A SE 9604752A SE 9604752 A SE9604752 A SE 9604752A SE 9604752 D0 SE9604752 D0 SE 9604752D0
Authority
SE
Sweden
Prior art keywords
pct
sec
date
pub
formulation
Prior art date
Application number
SE9604752A
Other languages
English (en)
Swedish (sv)
Inventor
Staffan Annefors
Carl-Axel Bauer
Hans Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9604752A priority Critical patent/SE9604752D0/xx
Publication of SE9604752D0 publication Critical patent/SE9604752D0/xx
Priority to FR9715245A priority patent/FR2757398B1/fr
Priority to IDW980046D priority patent/ID23693A/id
Priority to CN97192077A priority patent/CN1210464A/zh
Priority to PCT/SE1997/002053 priority patent/WO1998027981A1/en
Priority to PL97328334A priority patent/PL328334A1/xx
Priority to CZ982438A priority patent/CZ243898A3/cs
Priority to IL12553597A priority patent/IL125535A0/xx
Priority to TR1998/01500T priority patent/TR199801500T1/xx
Priority to US09/011,172 priority patent/US6075048A/en
Priority to AU78713/98A priority patent/AU7871398A/en
Priority to EP97949302A priority patent/EP0921795A1/en
Priority to JP10528671A priority patent/JP2001501225A/ja
Priority to ZA9711047A priority patent/ZA9711047B/xx
Priority to BR9707574A priority patent/BR9707574A/pt
Priority to CA002243085A priority patent/CA2243085A1/en
Priority to KR1019980706003A priority patent/KR19990082274A/ko
Priority to HU9901792A priority patent/HUP9901792A3/hu
Priority to ES009702568A priority patent/ES2131482B1/es
Priority to GR970100486A priority patent/GR1003207B/el
Priority to BE9701030A priority patent/BE1011395A5/fr
Priority to NL1007839A priority patent/NL1007839C2/nl
Priority to IE970899A priority patent/IE970899A1/en
Priority to NO983556A priority patent/NO983556D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9604752A 1996-12-20 1996-12-20 Formulation and use SE9604752D0 (sv)

Priority Applications (24)

Application Number Priority Date Filing Date Title
SE9604752A SE9604752D0 (sv) 1996-12-20 1996-12-20 Formulation and use
FR9715245A FR2757398B1 (fr) 1996-12-20 1997-12-03 Formulation de bambuterol et son utilisation
HU9901792A HUP9901792A3 (en) 1996-12-20 1997-12-09 An aqueous formulation comprising bambuterol and the use thereof
AU78713/98A AU7871398A (en) 1996-12-20 1997-12-09 An aqueous formulation comprising bambuterol and the use thereof
ZA9711047A ZA9711047B (en) 1996-12-20 1997-12-09 Formulation and use.
PCT/SE1997/002053 WO1998027981A1 (en) 1996-12-20 1997-12-09 An aqueous formulation comprising bambuterol and the use thereof
PL97328334A PL328334A1 (en) 1996-12-20 1997-12-09 Preparation and application thereof
CZ982438A CZ243898A3 (cs) 1996-12-20 1997-12-09 Vodná formulace bambuterolu a její použití
IL12553597A IL125535A0 (en) 1996-12-20 1997-12-09 An aqueous formulation comprising bambuterol and the use thereof
TR1998/01500T TR199801500T1 (xx) 1996-12-20 1997-12-09 Bambuterol i�eren bir sulu form�lasyon ve kullan�m�.
US09/011,172 US6075048A (en) 1996-12-20 1997-12-09 Pediatric method of use of bambuterol
IDW980046D ID23693A (id) 1996-12-20 1997-12-09 Formulasi bambuterol, pembuatan dan penggunaanya
EP97949302A EP0921795A1 (en) 1996-12-20 1997-12-09 An aqueous formulation comprising bambuterol and the use thereof
JP10528671A JP2001501225A (ja) 1996-12-20 1997-12-09 バムブテロールを含む水性製剤およびその使用
CN97192077A CN1210464A (zh) 1996-12-20 1997-12-09 含有班布特罗的含水制剂和其用途
BR9707574A BR9707574A (pt) 1996-12-20 1997-12-09 Formulacao aquosa de bambuterol processo para tratamento de uma crianca com necessidade de tratamento com um broncodilatador e uso de bambuterol
CA002243085A CA2243085A1 (en) 1996-12-20 1997-12-09 An aqueous formulation comprising bambuterol and the use thereof
KR1019980706003A KR19990082274A (ko) 1996-12-20 1997-12-09 밤부테롤을 함유하는 수성 제형 및 그의 용도
GR970100486A GR1003207B (el) 1996-12-20 1997-12-10 Νεοι φαρμακευτικοι σχηματισμοι και χρησεις βαμβουτερολης
ES009702568A ES2131482B1 (es) 1996-12-20 1997-12-10 Formulacion acuosa de bambuterol.
BE9701030A BE1011395A5 (fr) 1996-12-20 1997-12-17 Composition et utilisation.
NL1007839A NL1007839C2 (nl) 1996-12-20 1997-12-18 Formulering en gebruik.
IE970899A IE970899A1 (en) 1996-12-20 1997-12-18 Formulation and use
NO983556A NO983556D0 (no) 1996-12-20 1998-08-03 Formulering og anvendelse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604752A SE9604752D0 (sv) 1996-12-20 1996-12-20 Formulation and use

Publications (1)

Publication Number Publication Date
SE9604752D0 true SE9604752D0 (sv) 1996-12-20

Family

ID=20405108

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9604752A SE9604752D0 (sv) 1996-12-20 1996-12-20 Formulation and use

Country Status (24)

Country Link
US (1) US6075048A (el)
EP (1) EP0921795A1 (el)
JP (1) JP2001501225A (el)
KR (1) KR19990082274A (el)
CN (1) CN1210464A (el)
AU (1) AU7871398A (el)
BE (1) BE1011395A5 (el)
BR (1) BR9707574A (el)
CA (1) CA2243085A1 (el)
CZ (1) CZ243898A3 (el)
ES (1) ES2131482B1 (el)
FR (1) FR2757398B1 (el)
GR (1) GR1003207B (el)
HU (1) HUP9901792A3 (el)
ID (1) ID23693A (el)
IE (1) IE970899A1 (el)
IL (1) IL125535A0 (el)
NL (1) NL1007839C2 (el)
NO (1) NO983556D0 (el)
PL (1) PL328334A1 (el)
SE (1) SE9604752D0 (el)
TR (1) TR199801500T1 (el)
WO (1) WO1998027981A1 (el)
ZA (1) ZA9711047B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
CN104784106A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液的制备方法
CN104784108A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液组合物
CN110898003A (zh) * 2019-12-09 2020-03-24 岳阳新华达制药有限公司 一种新型盐酸班布特罗口服溶液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086363A (en) * 1977-03-16 1978-04-25 Usv Pharmaceutical Corporation Treatment of asthma
ATE7689T1 (de) * 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use

Also Published As

Publication number Publication date
NO983556L (no) 1998-08-03
ID23693A (id) 2000-05-11
FR2757398A1 (fr) 1998-06-26
TR199801500T1 (xx) 1999-02-22
IL125535A0 (en) 1999-03-12
PL328334A1 (en) 1999-01-18
ES2131482A1 (es) 1999-07-16
CN1210464A (zh) 1999-03-10
EP0921795A1 (en) 1999-06-16
WO1998027981A1 (en) 1998-07-02
CA2243085A1 (en) 1998-07-02
HUP9901792A2 (hu) 1999-10-28
ES2131482B1 (es) 2000-03-01
GR970100486A (el) 1998-08-31
GR1003207B (el) 1999-09-14
NL1007839A1 (nl) 1998-06-23
NL1007839C2 (nl) 1998-08-31
HUP9901792A3 (en) 2000-04-28
KR19990082274A (ko) 1999-11-25
FR2757398B1 (fr) 2000-09-01
NO983556D0 (no) 1998-08-03
BR9707574A (pt) 1999-07-27
AU7871398A (en) 1998-07-17
CZ243898A3 (cs) 1998-11-11
BE1011395A5 (fr) 1999-08-03
JP2001501225A (ja) 2001-01-30
IE970899A1 (en) 1998-10-07
ZA9711047B (en) 1998-06-22
US6075048A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
DK1191926T3 (da) Ny omeprazol- og (S)-omeprazolformulering
SE9504661D0 (sv) New compounds
IT1248702B (it) Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
HUP0104573A2 (hu) Agrokémiai készítmények
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
NO20004419L (no) Ny anvendelse
HUP9904109A2 (hu) Külsőleg használandó helyi érzéstelenítő
ES2163461T3 (es) Procedimiento para la obtencion de comprimidos efervescentes.
BR9509975A (pt) Formulação farmacêutica
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
SE9402880D0 (sv) New peptide derivatives
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
SE9604752D0 (sv) Formulation and use
ES2176805T3 (es) Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
SE0001916D0 (sv) Novel formulation
SE9504662D0 (sv) New compounds
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
SE9802538D0 (sv) New pharmaceutically active compounds